Egyptian Rheumatology and Rehabilitation

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 46  |  Issue : 2  |  Page : 108--112

Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behҫet’s disease


Nermeen A Fouad1, Tarek I Ahmed2, Olfat G Shaker3, Omayma O Abdelaleem4 
1 Department of Rheumatology and Rehabilitation, Faculty of Medicine, Fayoum University, Fayoum, Egypt
2 Department of Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt
3 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt
4 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, Egypt

Correspondence Address:
Nermeen A Fouad
Department of Rheumatology, Faculty of Medicine, Fayoum University, Fayoum, 63511
Egypt

Aim of work To determine level of ischemia-modified albumin (IMA) in patients with Behçet’s disease (BD) and to assess its role in disease manifestations and activity. Patients and methods The study included 48 patients with BD and 38 matched controls. Disease activity was estimated by the BD current activity form. Serum IMA was measured. Results Mean age of the patients was 33.8±7.9 years. There were 42 males and six females, and the disease duration was 52.9±48.8 months. The serum IMA level was significantly increased in the patients with BD (50.9±12.9 U/ml) compared with the control (7.76±1.6 U/ml) (P<0.001). There was a statistically significant association between IMA level and disease activity, with high mean IMA level among active cases (P=0.01). There was no statistically significant association between IMA level and any of other clinical characteristics in patients with BD. Sensitivity and specificity test for IMA level in detection of cases illustrated accuracy of 98.5% with sensitivity 95.8% and specificity 78.9% at cutoff value of 9.4 U/ml. Conclusion There is growing evidence indicating the role of oxidative stress in BD. IMA is accepted as an essential marker of oxidative stress in patients with BD. It has a potential diagnostic value for the detection of the disease. Furthermore, it correlates with the disease activity.


How to cite this article:
Fouad NA, Ahmed TI, Shaker OG, Abdelaleem OO. Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behҫet’s disease.Egypt Rheumatol Rehabil 2019;46:108-112


How to cite this URL:
Fouad NA, Ahmed TI, Shaker OG, Abdelaleem OO. Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behҫet’s disease. Egypt Rheumatol Rehabil [serial online] 2019 [cited 2019 Aug 22 ];46:108-112
Available from: http://www.err.eg.net/article.asp?issn=1110-161X;year=2019;volume=46;issue=2;spage=108;epage=112;aulast=Fouad;type=0